PORTUGU�S
Keywords:
microbiota intestinal, transplante fecal, clostridium difficileAbstract
ABSTRACT
GUT MICROBIOTA WAS ONCE CONSIDERED PATHOGENIC, BUT THE CONCEPT OF GUT MICROBIOTA AND ITS INFLUENCE ON HUMAN HEALTH IS UNDERGOING A MAJOR PARADIGM SHIFT AS THERE IS GROWING EVIDENCE OF ITS IMPACT ON INTESTINAL DEVELOPMENT HOMEOSTASIS, METABOLIC ACTIVITIES, AND THE IMMUNE SYSTEM. BASED ON THE ABOVE, THE PRESENT WORK AIMS TO DEAL WITH FECAL MICROBIOTA TRANSPLANTATION (FMT), ITS INDICATIONS AND CURRENT TECHNICAL PROTOCOLS. FOR THIS, AN EXPLORATORY-DESCRIPTIVE BIBLIOGRAPHIC REVIEW, OF A QUALITATIVE NATURE, WILL BE USED AS A METHODOLOGY. AND IT WILL DEAL IN ITS CHAPTERS ON THE CONCEPT OF INTESTINAL MICROBIOTA, THE HISTORY OF FMT, INDICATIONS AND CONTRAINDICATIONS OF TRANSPLANTATION AND ALSO, THE MAIN PROTOCOLS TO PERFORM THE PROCEDURE IN THE WORLD AND THE CURRENT SITUATION IN BRAZIL. FECAL MICROBIOTA TRANSPLANTATION IS AN INVESTIGATIONAL TREATMENT MODALITY. THUS, IT NEEDS SCIENTIFIC AND ETHICAL SUPPORT FOR ITS APPLICATION IN DAILY CLINICAL PRACTICE. IT SHOULD BE PERFORMED IN A RESEARCH ENVIRONMENT, IN CENTERS WITH EXPERIENCE IN THE TREATMENT AND WITH THE APPROVAL OF THE LOCAL ETHICS COMMITTEE, ESPECIALLY FOR CONDITIONS BEYOND THE ICD, FOR WHICH EVIDENCE OF BENEFIT IS STILL SCARCE. ITS USE OUTSIDE THESE MOLDS SHOULD BE DISCOURAGED IN BRAZIL.
KEYWORDS: GUT MICROBIOTA; FECAL TRANSPLANT; CLOSTRIDIUM DIFFICILE.
References
BAKKEN, J. S. et al. Treating Clostridium difficile Infection with Fecal Microbiota Transplantation. Clinical Gastroenterology and Hepatology. V. 9, n 12, 2014. DisponÃvel em: <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223289/>. Acesso em 03 maio. 2022.
GROOT, P, F. et al. Fecal microbiota transplantation in metabolic syndrome: History, present and future. National Library of Medicine. Fecal microbiota transplantation in metabolic syndrome: History, present and future. V. 8, n. 3, 2017.DisponÃvel em: <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479392/#:~:text=The%20history%20of%20fecal%20microbiota,and%20its%20resident%20microbial%20communities>. Acesso em 03 maio. 2022.
LEE, W. J. et al. Fecal Microbiota Transplantation: A Review of Emerging Indications Beyond Relapsing Clostridium difficile Toxin Colitis. Gastroenterology & Hepatology. V. 11, n. 1, 2015. DisponÃvel em:
<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836576/>. Acesso em 21 abr. 2022.
WANG, J. W. et al. Fecal microbiota transplantation: Review and update. Journal of the Formosan Medical Association, V. 118, S. 1, 2019. DisponÃvel em: <https://www.sciencedirect.com/science/article/pii/S0929664618305552>. Acesso em 26 abr. 2022.
ZHANG, T. Cost-effectiveness analysis of fecal microbiota transplantation for inflammatory bowel disease. Oncotarget. V. 8, n. 51, 2017. DisponÃvel em: <https://www.oncotarget.com/article/21491/text/>. Acesso em 26 abr. 2022.